Given that the uptake of lactate by myeloma PCs decreased anti‐myeloma efficacy of PIs, we next investigated whether MCT1 is differentially expressed in primary CD138+ cells from MM at diagnosis and resistant/refractory patients. The gene discussed is MCAT; the disease is plasma cell myeloma.